An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076645
Company: BAJAJ

Products on ANDA 076645

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LACTULOSE	LACTULOSE	10GM/15ML	SOLUTION;ORAL, RECTAL	Prescription	AA	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 076645

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/28/2003	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/20/2024	SUPPL-7	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 076645

LACTULOSE

SOLUTION;ORAL, RECTAL; 10GM/15ML
TE Code = AA

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
GENERLAC	LACTULOSE	10GM/15ML	SOLUTION;ORAL, RECTAL	Prescription	No	AA	074603	WOCKHARDT BIO AG
LACTULOSE	LACTULOSE	10GM/15ML	SOLUTION;ORAL, RECTAL	Prescription	No	AA	076645	BAJAJ
LACTULOSE	LACTULOSE	10GM/15ML	SOLUTION;ORAL, RECTAL	Prescription	No	AA	090502	FRESENIUS KABI

Top